Business Daily Media

Men's Weekly

.

FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US

  • Written by PR Newswire

HIGHLIGHTS

  • The US FDA has cleared Amplia's Investigational New Drug (IND) Application for a clinical trial of narmafotinib in the USA
  • The proposed trial would explore the combination of narmafotinib and FOLFIRINOX in advanced pancreatic cancer patients in the USA

MELBOURNE, Australia, Jan. 18, 2024 /PRNewswire/ -- Amplia Therapeutics...

Small business backlash builds as RBA’s surcharge ban risks fuelling inflation

Australia’s small business sector has launched a fierce campaign against the Reserve Bank of Australia’s (RBA) proposed ban on debit and credit card...

Australia’s Young Entrepreneurs Redefining Success Through Legacy and Community Impact

A new generation of young Australian small business owners is redefining success, driven by a desire to create a lasting legacy through the positi...

Lessons in AI: How LoanOptions.ai Shows What Smart Adoption Really Looks Like

In a world where many small businesses are still trying to work out how to actually use AI (not just talk about it), Australian fintech LoanOption...

Driving smarter: how car subscription models are redefining mobility and financial flexibility

The world of mobility is changing fast, and car ownership is no longer the default. Across Australia, professionals and businesses alike are seeki...

The Future of Wealth Technology

“You shouldn’t need a large account balance to experience real-time investing. Technology should make that kind of access universal.” For decades...

Thryv wins national accolade at 2025 Australian Service Excellence Awards

  Thryv® (NASDAQ: THRY), Australia’s provider of the leading small business marketing and sales software platform, announced that Greg Nicolle, G...